Complex immunohistochemical analysis of diffuse gliomas of the brain.

Authors

  • І. S. Shpon‘ka State establishment “Dnipropetrovsk medical academy of Health Ministry of Ukraine”, Ukraine
  • T. V. Shynkarenko State establishment “Dnipropetrovsk medical academy of Health Ministry of Ukraine”, Ukraine

DOI:

https://doi.org/10.26641/1997-9665.2017.3.39-46

Keywords:

diffuse glioma, immunohistochemistry, diagnostics, proliferation index, angiogenesis, intermediate filament, matrix metalloproteinase.

Abstract

Background. Differential diagnostics of diffuse gliomas is complicated by the morphological similarity of tumors that have a different malignant potential. Objective. Therefore, the aim of this study was to optimize the diagnostic morphological criteria of glial brain tumors on the basis of studying the immunohistochemical expression of markers of biological properties of cells. Methods. Range of primary antibodies (Ki-67, EGFR, p53, MGMT, MMP3, MMP9, GFAP, vimentin, cytokeratin AE1/AE3, IDH1 R132H) was used for IHC. Contingency tables were analyzed with Fisher's exact test. Spearmen rank coefficient was computed to identify a relationship between morphometric parameters and tumor Grade. Results. Authors have analyzed cell kinetics, apoptosis, DNA repair, proteolysis of extracellular matrix, metabolic disorders, and changes in the expression of intermediate filaments, angiogenesis. Immunophenotypes were defined for adult glial tumors (Grade II, Grade III and Grade IV; astrocytic and oligodendroglial gliomas). Morphological differential criteria were proposed. Conclusion. Immunophenotype characteristics of tumors of different histological type and WHO Grade were determined.

References

  1. Fedorenko ZP, Michailovich YoYo, Goulak LO, Gorokh YeL, Ryzhov AYu, Soumkina OV, Koutsenko LB. Cancer in Ukraine, 2015–2016. Bull Natl Cancer Register of Ukraine. 2017;18:56-7. Available from: http://www.ncru.inf.ua/publications/ BULL_18/PDF_E/bull_18_eng.pdf.
  2. Ostrom QT, Gittleman H, Xu J, Kromer C, Wolinsky Y, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2009–2013. Neuro-Oncology. 2016 Oct 1;18(5):1-75. doi: 10.1093/neuonc/now207.
  3. Cavenee WK, Leung SY, Hawkins C, Van Meir EG, Burger PC, Tabori U. WHO Classification of Tumours of the Central Nervous System, Revised. Lyon: IARC; 2016. 408 p. ISBN 978-92-832-4492-9.
  4. Zozulya YuA, Rozumenko VD, Malysheva TA, Sidorenko SP, Dmitrenko VV, Kavsan VM. [Molecular-genetic descriptions of intracerebral tu-mours and their value for individualization of treat-ment and prognosis of clinical course]. Zhurnal NAMN Ukrajiny. 2016;22(1):21-33. Ukrainian. Available from http://journal.amnu.gov.ua/site/journal.nsf/id/2E5BD05E9FFA5E9DC22580B00078AA0D/$file/Zozulia.pdf
  5. Stupp R, Brada M, Van Den Bent MJ, Tonn JC, Pentheroudakis G. High-grade glioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology. 2014 Apr 29;25(3):93-101. doi: 10.1093/annonc/mdu050.
  6. Jiang T, Mao Y, Ma W, Mao Q, You Y, Yang X, Jiang C, Kang C, Li X, Chen L, Qiu X. CGCG clinical practice guidelines for the management of adult diffuse gliomas. Cancer letters. 2016 Jun 1;375(2):263-73. doi: 10.1016/j.canlet.2016.01.024.
  7. Poslavska OV. [Methodology for the use of software for the analysis of digital micrographs on the base of pathomorphology course in order to increase the professional level of students and scien-tists]. Morphologia. 2015;9(3):122-6. Ukrainian. Available from http://www.morphology.dp.ua/ _pub/MORPHO-2015-09-03/15povrsn.pdf.
  8. Shpon‘ka IS, Shynkarenko TV, Poslavska OV. [Characterization and analysis of Ki-67-immunoreactivity in brain astrocytoma]. Morphologia. 2016;10(1):96-101. Ukrainian. Avail-able from http://www.morphology.dp.ua/_pub/MORPHO-2016-10-01/16sisagm.pdf.
  9. Antomonov M. [Mathematical processing and analysis of medical and biological data.] Kyiv: FMD; 2006. 558 p. Russian.
  10. Schiffer D. Brain tumors: biology, patholo-gy and clinical references. Springer Science & Busi-ness Media; 2012, 695 p.
  11. Lépinoux-Chambaud C, Eyer J. Review on intermediate filaments of the nervous system and their pathological alterations. Histochemistry and cell biology. 2013;140(1):13-22. doi: 10.1007/s00418-013-1101-1.
  12. Scheinemann K, Bouffet E, editors. Pediat-ric neuro-oncology. Springer; 2015, 318 p.
  13. Paw I, Carpenter RC, Watabe K, Debinski W, Lo HW. Mechanisms regulating glioma invasion. Cancer letters. 2015 Jun 28;362(1):1-7. doi: 10.1016/j.canlet.2015.03.015.
  14. Dimitrov L, Hong CS, Yang C, Zhuang Z, Heiss JD. New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma. International journal of medical sciences. 2015;12(3):201. doi: 10.7150%2Fijms.11047.

How to Cite

Shpon‘ka І. S., & Shynkarenko, T. V. (2017). Complex immunohistochemical analysis of diffuse gliomas of the brain. Морфологія / Morphologia / Morfologìâ, 11(3), 39–46. https://doi.org/10.26641/1997-9665.2017.3.39-46

Issue

Section

Статті